Extracellular matrix remodeling as a regulator of stromal-epithelial interactions during mammary gland development, involution and carcinogenesis

Brazilian Journal of Medical and Biological Research

Volumn 29, Issue 9, 1996, Pages 1087-1097

  Werb, Z ^a,b   Askenas, J ^a   MacAuley, A ^a   Wiesen, J F ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Apoptosis; Extracellular matrix; Mammary gland; Matrix metalloproteinases; Stromal epithelial interactions; Stromelysin 1

Indexed keywords

METALLOPROTEINASE; PROTEINASE INHIBITOR; STROMELYSIN;

ANIMAL; APOPTOSIS; ARTICLE; BREAST; CHEMISTRY; EPITHELIUM; EXTRACELLULAR MATRIX; GROWTH, DEVELOPMENT AND AGING; MOUSE; NEOPLASM; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; STROMA CELL;

ANIMALS; APOPTOSIS; BREAST; EPITHELIUM; EXTRACELLULAR MATRIX; MATRIX METALLOPROTEINASE 3; METALLOENDOPEPTIDASES; MICE; NEOPLASMS; PROTEASE INHIBITORS; STROMAL CELLS;

EID: 0030224843     PISSN: 0100879X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (65)

1. Stetler-Stevenson WG, Aznavoorian S & Liotta LA (1993). Tumor cell interactions with the extracellular matrix during invasion and metastasis. Annual Review of Cell Biology, 9: 541-573.
2. Ashkenas J, Damsky CH, Bissell MJ & Werb Z (1992). Integrins, signalling, and the remodeling of the extracellular matrix. In: Cheresh D & Mecham R (Editors), The Integrins. Academic Press, New York, 79-109.
3. Birkedal-Hansen H, Moore WGI, Boden MK, Windsor LJ, Birkedal-Hansen B, DeCarlo A & Engler JA (1993). Matrix metalloproteinases: A review. Critical Reviews in Oral Biology and Medicine, 4: 197-250.
4. Sato H, Takino T, Okada Y, Cao J, Shinagawa A, Yamamoto E & Seiki M (1994). A matrix metalloproteinase expressed on the surface of invasive tumor cells. Nature, 370: 61-65.
5. Freije JM, Diez-Itza I, Balbin M, Sanchez LM, Blasco R, Tolivia J & Lopez-Otin C (1994). Molecular cloning and expression of collagenase-3, a novel human matrix metalloproteinase produced by breast carcinomas. Journal of Biological Chemistry, 26: 16766-16773.
6. Basset P, Bellocq JP, Wolf C, Stoll I, Hutin P, Limacher JM, Podhajcer OL, Chenard MP, Rio MC & Chambon P (1990). A novel metalloproteinase gene specifically expressed in stromal cells of breast carcinomas. Nature, 348: 699-704.
7. Canete-Soler R, Litzky L, Lubensky I & Muschel RJ (1994). Localization of the 92 kd gelatinase mRNA in squamous cell and adenocarcinomas of the lung using in situ hybridization. American Journal of Pathology, 144: 518-527.
8. Witty JP, McDonnell S, Newell KJ, Cannon P, Navre M, Tressler RJ & Matrisian LM (1994). Modulation of matrilysin level in colon carcinoma cell lines affects tumorigenicity in vivo. Cancer Research, 54: 4805-4812.
9. Yamamoto H, Itoh F, Hinoda Y, Senota A, Yoshimoyo M, Nakamura MH, Imai K & Yachi A (1994). Expression of matrilysin mRNA in colorectal adenomas and its induction by truncated fibronectin. Biochemical and Biophysical Research Communications, 201: 657-664.
10. Mignatti P & Rifkin DB (1993). Biology and biochemistry of proteinases in tumor invasion. Physiological Reviews, 73: 161-195.
11. Crawford HC & Matrisian LM (1994). Tumor and stromal expression of matrix metalloproteinases and their role in tumor progression. Invasion and Metastasis, 14: 234-245.
12. Birkedal-Hansen H (1995). Proteolytic remodeling of extracellular matrix. Current Opinion in Cell Biology, 7: 728-735.
13. Leco KJ, Khokha R, Pavloff N, Hawkes SP & Edwards DR (1994). Tissue inhibitor of metalloproteinases-3 (TIMP-3) is an extracellular matrix-associated protein with a distinctive pattern of expression in mouse cells and tissues. Journal of Biological Chemistry, 269: 9352-9360.
14. Pendas AM, Matilla T, Estivill XA & Lopez-Otin C (1995). The human collagenase-3 (CLG-3) gene is located on chromosome 11q22.3 clustered to other members of the matrix metalloproteinase gene family. Genomics, 26: 615-618.
15. Pei D & Weiss SJ (1995). Furin-dependent intracellular activation of the human stromelysin-3 zymogen. Nature, 375: 244-247.
16. Pei D, Majmudar G & Weiss SJ (1994). Hydrolytic inactivation of a breast carcinoma cell-derived serpin by human stromelysin-3. Journal of Biological Chemistry, 269: 25849-25855.
17. Murphy G, Segain JP, O'Shea M, Cockett M, Ioannou C, Lefebvre O, Chambon P & Basset P (1993). The 28-kDa N-terminal domain of mouse stromelysin-3 has the general properties of a weak metalloproteinase. Journal of Biological Chemistry, 268: 15435-15441.
18. Rodgers WH, Osteen KG, Matrisian LM, Navre M, Guidice LC & Gorstein F (1993). Expression and localization of matrilysin, a matrix metalloproteinase in human endometrium during the reproductive cycle. Journal of Obstetrics and Gynecology, 168: 253-260.
19. Rodgers WH, Matrisian LM, Guidice LL, Dsupin B, Cannon P, Svitek C, Gorstein F & Osteen KG (1994). Patterns of matrix metalloproteinase expression in cycling endometrium imply differential functions and regulation by steroid hormones. Journal of Clinical Investigation, 94: 946-953.
20. Wilson CL, Heppner KJ, Rudolph LA & Matrisian LM (1995). The metalloproteinase matrilysin is preferentially expressed by epithelial cells in a tissue-restricted pattern in the mouse. Molecular Biology of the Cell. 6: 851-869.
21. Shapiro SD, Griffin GL, Gilbert DJ, Jenkins NA, Copeland NG, Welgus HG, Senior RM & Ley TJ (1992). Molecular cloning, chromosomal localization, and bacterial expression of a murine macrophage metalloelastase. Journal of Biological Chemistry, 267: 4664-4671.
22. Gack S, Vallon R, Schaper J, Ruther U & Angel P (1994). Phenotypic alterations in Fos-transgenic mice correlate with changes in Fos/Jun-dependent collagenase type I expression. Journal of Biological Chemistry, 269: 10363-10369.
23. Witty JP, Wright JH & Matrisian LM (1995). Matrix metalloproteinases are expressed during ductal and alveolar mammary morphogenesis, and misregulation of stromelysin-1 in transgenic mice induces unscheduled alveolar development. Molecular Biology of the Cell, 6:1287-1303.
24. Thomasset N, Sympson CJ, Leif LR, Werb Z & Bissell MJ (1994). Overexpression of stromelysin-1 modifies mammary gland stroma in transgenic mice. Molecular Biology of the Cell. 5 (Suppl): 181a.
25. Talhouk RS. Bissell MJ & Werb Z (1992). Coordinated expression of extracellular matrix-degrading proteinases and their inhibitors regulates mammary epithelial function during involution. Journal of Cell Biology. 118:1271-1282.
26. Sympson CJ, Talhouk RS, Alexander CM, Chin JR, Gift SM, Bissell MJ & Werb Z (1994). Targeted expression of stromelysin-1 in mammary gland provides evidence for a role of proteinases in branching morphogenesis and the requirement for an intact basement membrane for tissue-specific gene expression. Journal of Cell Biology, 125:681-693.
27. Lund LR, Romer J, Thomasset N, Solberg H, Pyke C, Bissell MJ, Dano K & Werb Z (1996). Two distinct phases of apoptosis in mammary gland involution: proteinase-independent and -dependent pathways. Development, 122:181-193.
28. Helminen HJ & Eriksson JLE (1968). Studies on mammary gland involution. I. On the ultrastructure of the lactating mammary gland. Journal of Ultrastructure Research, 25:193-213.
29. Lascelles AK & Lee CS (1978). Involution of the mammary gland. In: Larson BL & Smith VR (Editors), Lactation: A Comprehensive Treatise. Vol. 4. Academic Press, New York, 115-177.
30. Marti A, Jehn B, Costello E, Keon N, Ke G, Martin F & Jaggi R (1994). Protein kinase A and AP-1 Ic-Fos/JunD) are induced during apoptosis of mouse epithelial cells. Oncogene. 9:1213-1223.
31. Strange R, Li F, Saurer S, Burkhardt A & Friis RR (1992). Apoptotic cell death and tissue remodeling during mouse mammary gland involution. Development, 115:49-58.
32. Walker NI, Bennett RE & Kerr JFR (1989). Cell death by apoptosis during involution of the lactating breast in mice and rats. American Journal of Anatomy, 185: 19-32.
33. Williams WL (1942). Normal and experimental mammary involution in the mouse as related to the inception and cessation of lactation. American Journal of Anatomy, 71: 1-41.
34. Klagsbrun M (1992). Mediators of angiogenesis: the biological significance of basic fibroblast growth factor (bFGF)-heparin and heparin sulfate interactions. Seminars in Cancer Biology. 3: 81-87.
35. Sympson CJ, Talhouk RS, Bissell MJ & Werb Z (1995). The role of metalloproteinases and their inhibitors in regulating mammary epithelial morphology and function in vivo. Perspectives in Drug Discovery and Design, 2: 401-411.
36. van den Hooff A (1988). Stromal involvement in malignant growth. Advances in Cancer Research, 50: 159-196.
37. Weidner N, Folkman J, Pozza F, Bevilacqua P, Allred EN, Moore DH, Mei S & Gasparini G (1992). Tumor angiogenesis: A new significant and independent prognostic indicator in early stage breast carcinoma. Journal of the National Cancer Institute, 84: 1875-1887.
38. Sieweke MH & Bissell MJ (1994). The tumor promoting effect of wounding: a possible role for TGF-β-induced stromal alterations. Critical Reviews in Oncogenesis, 5: 297-311.
39. Boudreau N, Sympson CJ, Werb Z & Bissell MJ (1995). Suppression of ICE and apoptosis in mammary epithelial cells by extracellular matrix. Science, 267: 891-893.
40. Alexander CM, Howard EW, Bissell MJ & Werb Z (1996). Rescue of mammary epithelial cell apoptosis and entactin degradation by a TIMP-1 transgene. Journal of Cell Biology (in press).
41. Roskelley CD, Desprez PY & Bissell MJ (1994). Extracellular matrix-dependent tissue-specific gene expression in mammary epithelial cells requires both physical and biochemical signal transduction. Proceedings of the National Academy of Sciences, USA, 91: 12378-12382.
42. Streuli CH, Schmidhauser C, Bailey N, Yurchenco P, Skubitz APN, Roskelley C & Bissell MJ (1995). Laminin mediates tissue-specific gene expression in mammary epithelia. Journal of Cell Biology, 129: 591-603.
43. Feng Z, Marti A, Jehn B, Altermatt HJ, Chicaiza G & Jaggi R (1995). Glucocorticoid and progesterone inhibit involution and programmed cell death in the mouse mammary gland. Journal of Cell Biology, 131: 1095-1103.
44. Mignatti P, Robbins E & Bobbins DB (1986). Tumor invasion through the human amnion membrane: requirement for a proteinase cascade. Cell, 47: 487-498.
45. Schultz RM, Silberman S, Persky B, Bajkowski AS & Carmichael DF (1988). Inhibition by human recombinant tissue inhibitor of metalloproteinases of human amnion invasion and lung colonization by murine B16-F10 melanoma cells. Cancer Research, 48: 5539-5545.
46. Alvarez OA, Carmichael DF & DeClerck YA (1990). Inhibition of collagenolytic activity and metastasis of tumor cells by a recombinant human tissue inhibitor of metalloproteinases. Journal of the National Cancer Institute, 82: 589-595.
47. Khokha R (1994). Suppression of the tumorigenic and metastatic abilities of murine B16-F10 melanoma cells in vivo by the overexpression of the tissue inhibitor of the metalloproteinases-1. Journal of the National Cancer Institute, 86: 299-304.
48. Alexander CM & Werb Z (1992). Targeted disruption of the tissue inhibitor of metalloproteinases gene increases the invasive behavior of primitive mesenchymal cells derived from embryonic stem cells in vitro. Journal of Cell Biology, 118: 727-739.
49. Werb Z, Tremble PM, Behrendtsen O, Crowley E & Damsky CH (1989). Signal transduction through the fibronectin receptor induces metalloproteinase gene expression. Journal of Cell Biology, 109: 877-889.
50. Tremble PM, Chiquet-Ebrismann R & Werb Z (1994). The extracellular matrix ligands, tenascin and fibronectin, collaborate in regulating collagenase gene expression in fibroblasts. Molecular Biology of the Cell, 5: 439-453.
51. Giancotti FG & Ruoslahti E (1990). Elevated levels of the α5β1 fibronectin receptor suppress the transformed phenotype of Chinese hamster ovary cells. Cell, 60: 849-859.
52. Schwartz MA (1993). Signalling by integrins: Implications for tumorigenesis. Cancer Research, 53: 1503-1506.
53. Hynes RO & Plantefaber LC (1991). Integrin receptors for extracellular matrix and their involvement in oncogenic transformation. In: Brugge J, Curran T, Harlow E & McCormick F (Editors), Origins of Human Cancer: A Comprehensive Review. Cold Spring Harbor Laboratory Press, Plainview, NY, 297-307.
54. Steller H (1995). Mechanisms and genes of cellular suicide. Science, 267: 1445-1449.
55. Ashkenas J & Werb Z (1996). Proteolysis and the biochemistry of life-or-death decisions. Journal of Experimental Medicine, 183: 1-5.
56. Shi L, Nishioka WK, Th'ng J, Bradbury EM, Litchfield DW & Greenberg AH (1994). Premature p34cdc2 activation required for apoptosis. Science, 263: 1143-1145.
57. Fotedar R, Flatt J, Gupta S, Margolis RL, Fitzgerald P, Messier H & Fotedar A (1995). Activation-induced T-cell death is cell cycle dependent and regulated by cyclin B. Molecularand Cellular Biology, 15: 932-942.
58. Li CJ, Friedman DJ, Wang C, Metelev V & Pardee AB (1995). Induction of apoptosis in uninfected lymphocytes by HIV-1 Tat protein. Science, 268: 429-431.
59. Shimizu T, O'Connor PM, Kohn KW & Pommier Y (1995). Unscheduled activation of cyclin B1/Cdc2 kinase in human promyelocytic leukemia cell line HL60 cells undergoing apoptosis induced by DNA damage. Cancer Research, 55: 228-231.
60. Meikrantz W, Gisselbrecht S, Tam SW & Schlegel R (1994). Activation of cyclin A-dependent protein kinases during apoptosis. Proceedings of the National Academy of Sciences, USA, 91: 3754-3758.
61. Hoang AT, Cohen KJ, Barrett JF, Bergstrom DA & Dang CV (1994). Participation of cyclin A in Myc-induced apoptosis. Proceedings of the National Academy of Sciences, USA, 91: 6875-6879.
62. Boudreau N, Werb Z & Bissell MJ (1996). Suppression of apoptosis by basement membrane requires three-dimensional tissue organization and withdrawal from the cell cycle. Proceedings of the National Academy of Sciences, USA (in press).
63. Freeman RS, Estus S & Johnson Jr EM (1994). Analysis of cell cycle-related gene expression in postmitotic neurons: selective induction of cyclin D1 during programmed cell death. Neuron, 12: 343-355.
64. Furuya Y, Lin XS, Walsh JC, Nelson WG & Isaacs JT (1995). Androgen ablation-induced programmed death of prostatic glandular cells does not involve recruitment into a defective cell cycle or p53 induction. Endocrinology, 136: 1898-1906.
65. Oberhammer FA, Hochegger K, Froschl G, Tiefenbacher R & Pavelka M (1994). Chromatin condensation during apoptosis is accompanied by degradation of laminin A+B, without enhanced activation of cdc2 kinase. Journal of Cell Biology, 126: 827-837.